Michael S. Brown, Director at REGENERON PHARMACEUTICALS INC (REGN), sold 6,500 shares at $380.49 ($571K) on 2018-08-22, disclosed to the SEC on 2018-08-23.
Open-market sale of $571k REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 5,000 | $0 | 0.0% |
| 2 | $380.49 | 1,500 | $571K | 100.0% |
| Total | $87.81 avg | 6,500 | $571K | 100% |
| Filing → |
| REGN | SELL | 2023-12-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-04-24 | $4.9M | — | Filing → |
| REGN | SELL | 2023-02-08 | $2.8M | — | Filing → |